MENU
+Compare
REVS
ETF ticker: NYSE ARCA
AS OF
Jul 18, 04:59 PM (EDT)
Price
$26.57
Change
-$0.01 (-0.04%)
Net Assets
77.84M

REVS stock forecast, quote, news & analysis

The investment seeks investment results that, before fees and expenses, closely correspond to the performance of the Beta Advantage® Research Enhanced U... Show more

Category: #Large Value
REVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for REVS with price predictions
Jul 17, 2025

REVS sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for REVS moved above the 200-day moving average on July 02, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where REVS advanced for three days, in of 344 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 346 cases where REVS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for REVS moved out of overbought territory on July 11, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 45 similar instances where the indicator moved out of overbought territory. In of the 45 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on July 16, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on REVS as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for REVS turned negative on July 15, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where REVS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

REVS broke above its upper Bollinger Band on July 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are JPMorgan Chase & Co (NYSE:JPM), Exxon Mobil Corp (NYSE:XOM), ABBVIE (NYSE:ABBV), Bank of America Corp (NYSE:BAC), Salesforce (NYSE:CRM), Chevron Corp (NYSE:CVX), Philip Morris International (NYSE:PM), Walt Disney Company (The) (NYSE:DIS), Wells Fargo & Co (NYSE:WFC), Cisco Systems (NASDAQ:CSCO).

Industry description

The investment seeks investment results that, before fees and expenses, closely correspond to the performance of the Beta Advantage® Research Enhanced U.S. Value Index. The fund invests at least 80% of its assets in the securities of the index. The index reflects a rules-based strategic beta approach to investing in the companies that comprise the Russell 1000® Value Index, designed to achieve stronger total return when compared to the Russell 1000® Value Index, which is a broad measure of the performance of U.S. large- and mid-cap value companies.

Market Cap

The average market capitalization across the Columbia Research Enhanced Value ETF ETF is 36.7B. The market cap for tickers in the group ranges from 448.17M to 573.02B. JPM holds the highest valuation in this group at 573.02B. The lowest valued company is FTRE at 448.17M.

High and low price notable news

The average weekly price growth across all stocks in the Columbia Research Enhanced Value ETF ETF was 14%. For the same ETF, the average monthly price growth was 35%, and the average quarterly price growth was 53%. UI experienced the highest price growth at 12%, while GRAL experienced the biggest fall at -17%.

Volume

The average weekly volume growth across all stocks in the Columbia Research Enhanced Value ETF ETF was -5%. For the same stocks of the ETF, the average monthly volume growth was 3% and the average quarterly volume growth was 10%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 52
Price Growth Rating: 47
SMR Rating: 56
Profit Risk Rating: 51
Seasonality Score: 25 (-100 ... +100)
View a ticker or compare two or three
REVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category LargeValue

Profile
Fundamentals
Details
Category
Large Value
Address
Columbia ETF Trust I225 Franklin Street, Boston, MassachusettsBoston
Phone
617-426-3750
Web
N/A